natgillin/translations-raw huggingface dataset:
N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]cyclopropanecarboxamide (cyclopropylfentanyl) and 2-methoxy-N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]acetamide (methoxyacetylfentanyl) subjected to control measures by Council Implementing Decision (EU) 2018/1463.
Direktiva (EU) 2017/2103 za Združeno kraljestvo ni zavezujoča, zato Združeno kraljestvo ne sodeluje pri sprejetju in uporabi te delegirane direktive, ki zato zanj ni zavezujoča ter se v njem ne uporablja.
Ireland is bound by Directive (EU) 2017/2103 and is therefore taking part in the adoption and application of this delegated directive.
Direktiva (EU) 2017/2103 za Dansko ni zavezujoča, zato Danska ne sodeluje pri sprejetju in uporabi te delegirane direktive, ki zato zanjo ni zavezujoča ter se v njej ne uporablja.
The United Kingdom is not bound by Directive (EU) 2017/2103 and is therefore not taking part in the adoption and application of this delegated directive and is not bound by it or subject to its application.
Okvirni Sklep 2004/757/PNZ bi bilo zato treba ustrezno spremeniti –
Denmark is not bound by Directive (EU) 2017/2103 and is therefore not taking part in the adoption and application of this delegated directive and is not bound by it or subject to its application.
SPREJELA NASLEDNJO DIREKTIVO:
Framework Decision 2004/757/JHA should therefore be amended accordingly,
Člen 1
HAS ADOPTED THIS DIRECTIVE:
Sprememba Okvirnega sklepa 2004/757/PNZ
Article 1
Na seznam iz Priloge k Okvirnem sklepu 2004/757/PNZ se doda naslednje:
Amendment to Framework Decision 2004/757/JHA
N-fenil-N-[1-(2-feniletil)piperidin-4-il]furan-2-karboksamid (furanilfentanil), kot je naveden v Izvedbenem sklepu Sveta (EU) 2017/2170;
The following is added to the list in the Annex to Framework Decision 2004/757/JHA:
N-(1-amino-3,3-dimetil-1-oksobutan-2-il)-1-(cikloheksilmetil)-1H-indazol-3-karboksamid (ADB-CHMINACA), kot je naveden v Izvedbenem sklepu Sveta (EU) 2018/747;
N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]furan-2-carboxamide (furanylfentanyl), as referred to in Council Implementing Decision (EU) 2017/2170.
1-(4-cianobutil)-N-(2-fenilpropan-2-il)-1H-indazol-3-karboksamid (CUMYL-4CN-BINACA), kot je naveden v Izvedbenem sklepu Sveta (EU) 2018/748;
N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide (ADB-CHMINACA), as referred to in Council Implementing Decision (EU) 2018/747.
N-fenil-N-[1-(2-feniletil)piperidin-4-il]ciklopropankarboksamid (ciklopropilfentanil) in 2-metoksi-N-fenil-N-[1-(2-feniletil)piperidin-4-il]acetamid (metoksiacetilfentanil), kot sta navedena v Izvedbenem sklepu Sveta (EU) 2018/1463.
1-(4-cyanobutyl)-N-(2-phenylpropan-2-yl)-1H-indazole-3-carboxamide (CUMYL-4CN-BINACA), as referred to in Council Implementing Decision (EU) 2018/748.
Člen 2
N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]cyclopropanecarboxamide (cyclopropylfentanyl) and 2-methoxy-N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]acetamide (methoxyacetylfentanyl), as referred to in Council Implementing Decision (EU) 2018/1463.
Prenos
However, they shall bring into force the laws, regulations and administrative provisions necessary to comply with point 16 of the Annex to Framework Decision 2004/757/JHA referred to in Article 1 of this Directive by 29 September 2019.
Začetek veljavnosti
Member States shall determine how such reference is to be made.
Ta direktiva je naslovljena na države članice v skladu s Pogodbama.
Member States shall communicate to the Commission the text of the main provisions of national law which they adopt in the field covered by this Directive.
V Bruslju, 13. decembra 2018
This Directive shall enter into force on the twentieth day following that of its publication in the Official Journal of the European Union.
UL L 305, 21.11.2017, str. 12.
Article 4
Okvirni sklep Sveta 2004/757/PNZ z dne 25. oktobra 2004 o opredelitvi minimalnih določb glede elementov kaznivih dejanj in kazni na področju nedovoljenega prometa s prepovedanimi drogami (UL L 335, 11.11.2004, str. 8).
This Directive is addressed to the Member States in accordance with the Treaties.
Sklep Sveta 2005/387/PNZ z dne 10. maja 2005 o izmenjavi podatkov, oceni tveganja in nadzoru nad novimi psihoaktivnimi snovmi (UL L 127, 20.5.2005, str. 32).
Done at Brussels, 13 December 2018.
Izvedbeni sklep Sveta (EU) 2017/2170 z dne 15. novembra 2017 o uvedbi nadzornih ukrepov za N-fenil-N-[1-(2-feniletil)piperidin-4-il]furan-2-karboksamid (furanilfentanil) (UL L 306, 22.11.2017, str. 19).
For the Commission
Izvedbeni sklep Sveta (EU) 2018/747 z dne 14. maja 2018 o uvedbi nadzornih ukrepov za novo psihoaktivno snov N-(1-amino-3,3-dimetil-1-oksobutan-2-il)-1-(cikloheksilmetil)-1H-indazol-3-karboksamid (ADB-CHMINACA) (UL L 125, 22.5.2018, str. 8).
The President
Izvedbeni sklep Sveta (EU) 2018/748 z dne 14. maja 2018 o uvedbi nadzornih ukrepov za novo psihoaktivno snov 1-(4-cianobutil)-N-(2-fenilpropan-2-il)-1H-indazol-3-karboksamid (CUMYL-4CN-BINACA) (UL L 125, 22.5.2018, str. 10).
OJ L 305, 21.11.2017, p. 12.
Izvedbeni sklep Sveta (EU) 2018/1463 z dne 28. septembra 2018 o uvedbi nadzornih ukrepov za novi psihoaktivni snovi N-fenil-N-[1-(2-feniletil)piperidin-4-il]ciklopropankarboksamid (ciklopropilfentanil) in 2-metoksi-N-fenil-N-[1-(2-feniletil)piperidin-4-il]acetamid (metoksiacetilfentanil) (UL L 245, 1.10.2018, str. 9).
Council Framework Decision 2004/757/JHA of 25 October 2004 laying down minimum provisions on the constituent elements of criminal acts and penalties in the field of illicit drug trafficking (OJ L 335, 11.11.2004, p. 8).
Izvedbeni sklep Sveta (EU) 2018/747 z dne 14. maja 2018 o uvedbi nadzornih ukrepov za novo psihoaktivno snov N-(1-amino-3,3-dimetil-1-oksobutan-2-il)-1-(cikloheksilmetil)-1H-indazol-3-karboksamid (ADB-CHMINACA) (UL L 125, 22.5.2018, str. 8).
Council Decision 2005/387/JHA of 10 May 2005 on the information exchange, risk-assessment and control of new psychoactive substances (OJ L 127, 20.5.2005, p. 32).
Izvedbeni sklep Sveta (EU) 2018/1463 z dne 28. septembra 2018 o uvedbi nadzornih ukrepov za novi psihoaktivni snovi N-fenil-N-[1-(2-feniletil)piperidin-4-il]ciklopropankarboksamid (ciklopropilfentanil) in 2-metoksi-N-fenil-N-[1-(2-feniletil)piperidin-4-il]acetamid (metoksiacetilfentanil) (UL L 245, 1.10.2018, str. 9).“
Council Implementing Decision (EU) 2017/2170 of 15 November 2017 on subjecting N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]furan-2-carboxamide (furanylfentanyl) to control measures (OJ L 306, 22.11.2017, p. 19).
Direktiva (EU) 2017/2103 je razveljavila Sklep 2005/387/PNZ z učinkom od 23. novembra 2018.
Council Implementing Decision (EU) 2018/747 of 14 May 2018 on subjecting the new psychoactive substance N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide (ADB-CHMINACA) to control measures (OJ L 125, 22.5.2018, p. 8).
Od sprejetja Direktive (EU) 2017/2103 do 23. novembra 2018 so bili za pet novih psihoaktivnih snovi uvedeni nadzorni ukrepi in kazenske sankcije v skladu s Sklepom 2005/387/PNZ.
Council Implementing Decision (EU) 2018/748 of 14 May 2018 on subjecting the new psychoactive substance 1-(4-cyanobutyl)-N-(2-phenylpropan-2-yl)-1H-indazole-3-carboxamide (CUMYL-4CN-BINACA) to control measures (OJ L 125, 22.5.2018, p. 10).
Države članice sprejmejo zakone in druge predpise, potrebne za uskladitev s to direktivo, najpozneje do 7. septembra 2019.
Council Implementing Decision (EU) 2018/1463 of 28 September 2018 on subjecting the new psychoactive substances N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]cyclopropanecarboxamide (cyclopropylfentanyl) and 2-methoxy-N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]acetamide (methoxyacetylfentanyl) to control measures (OJ L 245, 1.10.2018, p. 9).
Vendar pa sprejmejo zakone in druge predpise, potrebne za uskladitev s točko 16 Priloge k Okvirnemu sklepu 2004/757/PNZ, ki je navedena v členu 1 te direktive, do 29. septembra 2019.
Council Implementing Decision (EU) 2018/747 of 14 May 2018 on subjecting the new psychoactive substance N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide (ADB-CHMINACA) to control measures (OJ L 125, 22.5.2018, p. 8).
Komisiji nemudoma sporočijo besedila navedenih predpisov.
Council Implementing Decision (EU) 2018/1463 of 28 September 2018 on subjecting the new psychoactive substances N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]cyclopropanecarboxamide (cyclopropylfentanyl) and 2-methoxy-N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]acetamide (methoxyacetylfentanyl) to control measures (OJ L 245, 1.10.2018, p. 9).’.
Države članice se v sprejetih predpisih sklicujejo na to direktivo ali pa sklic nanjo navedejo ob njihovi uradni objavi.
Regulation (EU) 2019/2 of the European Parliament and of the Council
Uredba (EU) 2019/2 Evropskega parlamenta in Sveta
amending Regulation (EC) No 1008/2008 on common rules for the operation of air services in the Community
o spremembi Uredbe (ES) št. 1008/2008 o skupnih pravilih za opravljanje zračnih prevozov v Skupnosti
Regulation (EC) No 1008/2008 of the European Parliament and of the Council includes provisions allowing lease agreements for aircraft registered in third countries, in particular wet lease agreements.
Uredba (ES) št. 1008/2008 Evropskega parlamenta in Sveta vsebuje določbe, ki dopuščajo zakupne pogodbe za zrakoplove, registrirane v tretjih državah, zlasti zakupne pogodbe s posadko.
Those agreements are permitted in exceptional circumstances, such as in the case of a lack of adequate aircraft in the Union market.
Te zakupne pogodbe so dovoljene v izjemnih razmerah, kot denimo v primeru pomanjkanja ustreznega zrakoplova na trgu Unije.
They should be strictly limited in time and should fulfil safety standards equivalent to the safety rules provided for in Union and national law.
Morale bi biti strogo časovno omejene ter izpolnjevati varnostne standarde, enakovredne varnostnim pravilom, ki so določena v pravu Unije in nacionalnem pravu.
The ATA reflects its parties' commitment to the shared goal of continuing to remove market access barriers in order to maximise benefits for consumers, airlines, labour and communities on both sides of the Atlantic.
Zadevne določbe, zajete v členu 10 Sporazuma o zračnem prometu, dovoljujejo zakupne pogodbe s posadko v mednarodnem zračnem prometu, pod pogojem, da imajo vse stranke takšnih zakupnih pogodb ustrezno pooblastilo in izpolnjujejo pogoje, predpisane v zakonih in drugih predpisih, ki jih pogodbenici Sporazuma o zračnem prometu običajno uporabljata.
The ATA provides for an open wet-lease regime between its parties.
Povezani razvoj in pretekle razprave skupnega odbora, vzpostavljenega na podlagi Sporazuma o zračnem prometu, so pokazali, da bi pogodbenici navedenega sporazuma imeli koristi od namenske zakupne pogodbe s posadko, ki bi natančneje opredelila zadevne določbe navedenega sporazuma.
The relevant provisions that are included under Article 10 of the ATA permit wet lease agreements for international air transport, provided that all parties to such agreements have the appropriate authority and meet the conditions prescribed under the laws and regulations normally applied by the parties to the ATA.
Ker bi taka zakupna pogodba s posadko vsebovala sprostitev obstoječih časovnih omejitev, bi imela verižni učinek na Uredbo (ES) št. 1008/2008, v kateri so določene časovne omejitve za primere, ko prevozniki iz Unije zakupijo zrakoplove s posadko od prevoznikov iz tretjih držav.
Relevant developments and past discussions of the Joint Committee established under the ATA have shown that parties to the ATA would benefit from a dedicated wet lease agreement which would provide precision to the relevant provisions of the ATA.
Uredbo (ES) št. 1008/2008 je zato treba spremeniti, da se omogoči sprostitev časovnih omejitev za zakup s posadko, o katerih se Unija dogovori v mednarodnih sporazumih, sklenjenih s tretjimi državami.
Since such a wet lease agreement would involve the relaxation of the existing time limits, it would have a ripple effect on Regulation (EC) No 1008/2008, in which time limits are provided for in cases where Union carriers wet lease from third-country carriers.
Glede na to, da Komisija trenutno pregleduje Uredbo (ES) št. 1008/2008, vključno z določbami o zakupu s posadko in njihovimi morebitnimi posledicami za zaposlene in potrošnike, ter da bi pregled Komisije lahko privedel do splošne revizije Uredbe (ES) št. 1008/2008, je ta uredba omejena na uskladitev Uredbe (ES) št. 1008/2008 z ustreznimi mednarodnimi obveznostmi.
Regulation (EC) No 1008/2008 therefore needs to be amended to allow for the relaxation of time limits on wet-leasing to be agreed in international agreements concluded by the Union with third countries.
Mednarodni sporazum o zakupu s posadko bi moral vključevati vzajemne pravice in obveznosti obeh strani ter temeljiti na obstoječem sporazumu o zračnem prometu.
Taking into account the fact that the Commission is currently reviewing Regulation (EC) No 1008/2008, including its provisions on wet-leasing and their possible impact on employees and consumers, and that the Commission's review could lead to a general revision of Regulation (EC) No 1008/2008, this Regulation is limited to aligning Regulation (EC) No 1008/2008 with the relevant international obligations.
Uredbo (ES) št. 1008/2008 bi bilo zato treba ustrezno spremeniti –
The international agreement on wet-leasing should include reciprocal rights and obligations for both parties and should be based on an existing Air Transport Agreement.
SPREJELA NASLEDNJO UREDBO:
Regulation (EC) No 1008/2008 should therefore be amended accordingly,
Člen 1
HAVE ADOPTED THIS REGULATION:
V točki (b) člena 13(3) Uredbe (ES) št. 1008/2008 se uvodni stavek nadomesti z naslednjim:
Article 1
„je izpolnjen eden od naslednjih pogojev, razen če je drugače določeno v mednarodnem sporazumu o zakupu s posadko, ki ga podpiše Unija in ki temelji na sporazumu o zračnem prometu, podpisanem pred 1. januarjem 2008 in katerega pogodbenica je Unija:“.
In point (b) of Article 13(3) of Regulation (EC) No 1008/2008, the introductory phrase is replaced by the following:
Člen 2
‘unless otherwise provided for in an international agreement on wet-leasing signed by the Union which is based on an Air Transport Agreement to which the Union is a party and which was signed before 1 January 2008, one of the following conditions is fulfilled:’.
Ta uredba začne veljati dvajseti dan po objavi v Uradnem listu Evropske unije.
This Regulation shall enter into force on the twentieth day following that of its publication in the Official Journal of the European Union.
V Strasbourgu, 11. decembra 2018
Done at Strasbourg, 11 December 2018.
Predsednica
The President
UL C 345, 13.10.2017, str. 126.
For the Council
Stališče Evropskega parlamenta z dne 29. novembra 2018 (še ni objavljeno v Uradnem listu) in odločitev Sveta z dne 6. decembra 2018.
OJ C 345, 13.10.2017, p. 126.
Uredba (ES) št. 1008/2008 Evropskega parlamenta in Sveta z dne 24. septembra 2008 o skupnih pravilih za opravljanje zračnih prevozov v Skupnosti (UL L 293, 31.10.2008, str. 3).
Position of the European Parliament of 29 November 2018 (not yet published in the Official Journal) and decision of the Council of 6 December 2018.
UL L 134, 25.5.2007, str. 4.
Regulation (EC) No 1008/2008 of the European Parliament and of the Council of 24 September 2008 on common rules for the operation of air services in the Community (OJ L 293, 31.10.2008, p. 3).
Sporazum o zračnem prometu med Evropsko skupnostjo in njenimi državami članicami na eni strani in Združenimi državami Amerike na drugi je bil podpisan 25. aprila 2007 in naknadno spremenjen s Protokolom z dne 24. junija 2010.
OJ L 134, 25.5.2007, p. 4.
Sporazum o zračnem prometu odraža zavezo pogodbenic k skupnemu cilju nadaljnjega odstranjevanja ovir za dostop na trg, da bi čim bolj povečali koristi za uporabnike, letalske družbe, delovno silo in skupnosti na obeh straneh Atlantika.
Regulation (EU) 2019/4 of the European Parliament and of the Council
Uredba (EU) 2019/4 Evropskega parlamenta in Sveta
of 11 December 2018
z dne 11. decembra 2018
on the manufacture, placing on the market and use of medicated feed, amending Regulation (EC) No 183/2005 of the European Parliament and of the Council and repealing Council Directive 90/167/EEC
o proizvodnji, dajanju v promet in uporabi medicirane krme, spremembi Uredbe (ES) št. 183/2005 Evropskega parlamenta in Sveta ter razveljavitvi Direktive Sveta 90/167/EGS
Having regard to the Treaty on the Functioning of the European Union, and in particular Article 43(2) and point (b) of Article 168(4) thereof,
ob upoštevanju Pogodbe o delovanju Evropske unije in zlasti člena 43(2) ter točke (b) člena 168(4) Pogodbe,
Council Directive 90/167/EEC constitutes the Union’s regulatory framework for the preparation, placing on the market and use of medicated feed.
Direktiva Sveta 90/167/EGS predstavlja regulativni okvir Unije za proizvodnjo, dajanje v promet in uporabo medicirane krme.
Livestock production occupies a very important place in the agriculture of the Union.
Živinoreja ima zelo pomembno vlogo v kmetijstvu Unije.
The rules concerning medicated feed have a significant influence on the keeping and on the rearing of animals, including non-food-producing animals, and on the production of products of animal origin.
Pravila o medicirani krmi pomembno vplivajo na rejo živali, tudi živali, ki niso namenjene proizvodnji živil, ter na proizvodnjo proizvodov živalskega izvora.
The pursuit of a high level of protection of human health is one of the fundamental objectives of Union food law, as laid down in Regulation (EC) No 178/2002 of the European Parliament and of the Council, and the general principles laid down in that Regulation should apply to the placing on the market and use of feed without prejudice to more specific Union legislation.
Doseganje visoke ravni varovanja zdravja ljudi je eden od temeljnih ciljev živilske zakonodaje Unije, kakor je določeno v Uredbi (ES) št. 178/2002 Evropskega parlamenta in Sveta, in splošna načela iz navedene uredbe bi se morala uporabljati za dajanje v promet in uporabo krme brez poseganja v bolj specifično zakonodajo Unije.
In addition, the protection of animal health constitutes one of the general objectives of Union food law.
Poleg tega je varovanje zdravja živali eden od splošnih ciljev živilske zakonodaje Unije.
Prevention of disease is better than cure.
Bolezni je bolje preprečevati kot zdraviti.
Medicinal treatments, especially with antimicrobials, should never replace good husbandry, bio-security and management practices.
Zdravljenje, zlasti s protimikrobnimi snovmi, nikoli ne bi smelo nadomestiti dobrih praks na področju reje, biološke zaščite in upravljanja.
Experience with the application of Directive 90/167/EEC has shown that further measures should be taken to strengthen the effective functioning of the internal market and to explicitly give and improve the possibility to treat non-food-producing animals with medicated feed.
Izkušnje z uporabo Direktive 90/167/EGS so pokazale, da bi bilo treba sprejeti nadaljnje ukrepe za okrepitev učinkovitega delovanja notranjega trga ter izrecno zagotovitev in izboljšanje možnosti za zdravljenje živali, ki niso namenjene proizvodnji živil, z medicirano krmo.
Medicated feed is one of the routes for the oral administration of veterinary medicinal products.
Medicirana krma je eden od načinov peroralnega vnosa zdravil za uporabo v veterinarski medicini.
Medicated feed is a homogeneous mixture of feed and veterinary medicinal products.
Medicirana krma je homogena mešanica krme in zdravil za uporabo v veterinarski medicini.
Other routes for oral administration, such as mixing of water for drinking with a veterinary medicinal product or manual mixing of a veterinary medicinal product into feed should not fall within the scope of this Regulation.
Druge oblike peroralnega vnosa, kot je mešanje vode za pitje z zdravilom za uporabo v veterinarski medicini ali ročno mešanje zdravil za uporabo v veterinarski medicini v krmo, ne bi smele biti vključene v področje uporabe te uredbe.
The authorisation for use in feed, the manufacture, distribution, advertising and supervision of those veterinary medicinal products are governed by Regulation (EU) 2019/6 of the European Parliament and of the Council.
Dovoljenje za uporabo v krmi, proizvodnja, distribucija, oglaševanje in nadzor teh zdravil za uporabo v veterinarski medicini so določeni v Uredbi (EU) 2019/6 Evropskega parlamenta in Sveta.
Regulation (EU) 2019/6 applies to veterinary medicinal products, including those products which Directive 90/167/EEC referred to as ‘pre-mixes’, until such time as those products are included in medicated feed or intermediate products, after which this Regulation applies to the exclusion of Regulation (EU) 2019/6.
Uredba (EU) 2019/6 se uporablja za zdravila za uporabo v veterinarski medicini, vključno s tistimi zdravili, ki so v Direktivi 90/167/EGS navedeni kot „premiks“, do vključitve teh zdravil v medicirano krmo ali vmesne proizvode, nato pa se ta uredba uporablja namesto Uredbe (EU) 2019/6.
As a type of feed, medicated feed and intermediate products fall within the scope of Regulations (EC) No 183/2005, (EC) No 767/2009, (EC) No 1831/2003 and Directive 2002/32/EC of the European Parliament and of the Council.
Medicirana krma in vmesni proizvodi kot vrsta krme spadajo v področje uporabe uredb (ES) št. 183/2005, (ES) št. 767/2009, (ES) št. 1831/2003 ter Direktive 2002/32/ES Evropskega parlamenta in Sveta.
Thus, whenever medicated feed is manufactured with a compound feed all relevant Union legislation on compound feed applies and whenever medicated feed is manufactured from a feed material, all relevant Union legislation on feed material applies.
Kadar je medicirana krma proizvedena s krmno mešanico, se zato uporablja vsa ustrezna zakonodaja Unije o krmnih mešanicah, kadar pa je medicirana krma proizvedena iz posamičnega krmila, se uporablja vsa ustrezna zakonodaja Unije o posamičnih krmilih.
This applies to feed business operators, whether they operate in a feed mill, with a specially equipped vehicle or on-farm, as well as to feed business operators storing, transporting or placing on the market medicated feed and intermediate products.
To velja za nosilce dejavnosti poslovanja s krmo, ne glede na to, ali delujejo v obratu za proizvodnjo krme, imajo posebej opremljeno vozilo ali imajo mešalce na kmetijskih gospodarstvih, ter za nosilce dejavnosti poslovanja s krmo, ki skladiščijo, prevažajo ali dajejo v promet medicirano krmo in vmesne proizvode.
Specific provisions for medicated feed and intermediate products should be established concerning facilities and equipment, personnel, manufacture, quality control, storage, transport, record-keeping, complaints, product recalls and labelling.
Treba bi bilo vzpostaviti posebne določbe za medicirano krmo in vmesne proizvode, in sicer glede prostorov in opreme, zaposlenih, kontrole, kakovosti pri proizvodnji, skladiščenja, prevoza, vodenja evidenc, pritožb, odpoklica proizvodov ter označevanja.
Medicated feed imported into the Union must satisfy the general obligations laid down in Article 11 of Regulation (EC) No 178/2002 and the import conditions laid down in Regulation (EC) No 183/2005 and in Regulation (EU) 2017/625 of the European Parliament and of the Council.
Medicirana krma, ki se uvozi v Unijo, mora izpolnjevati splošne obveznosti iz člena 11 Uredbe (ES) št. 178/2002 ter uvozne pogoje iz Uredbe (ES) št. 183/2005 in Uredbe (EU) 2017/625 Evropskega parlamenta in Sveta.
Within that framework, medicated feed imported into the Union should be considered as falling within the scope of this Regulation.
V tem okviru bi za medicirano krmo, ki se uvozi v Unijo, moralo veljati, da spada v področje uporabe te uredbe.